Digestive Disorders and Lifestyle Factors

Prevalence and Characteristics

The American Gastroenterological Association notes that irritable bowel syndrome (IBS) affects 9-12% of the general population, with a female-to-male ratio ranging from 1.1 to 2.6 depending on symptom criteria used 1
IBS accounts for approximately 40-60% of gastroenterology outpatient referrals, with patients experiencing significantly impaired quality of life, often worse than those with end-stage renal disease 1, 2

The American College of Gastroenterology recommends that patients with IBS avoid large meals and late-night eating, as these are specific behavioral perpetuating factors within patient control 3
Approximately 50% of hospital outpatients with IBS attribute symptom onset to a stressful life event, and substantial life stress, strong negative emotions, and inadequate sleep disturb normal brain-gut communication 1, 3
Poor quality and inadequate quantity of sleep are potent symptom contributors that patients can control, with disturbed sleep being more frequent in IBS patients and contributing to lethargy and inability to function normally 3, 4, 5
Lack of physical activity is a potent symptom contributor that can be modified, with sedentary lifestyle contributing to both symptom severity and psychological comorbidities 3

Over 40% of patients avoid activities including work, travel, socializing, sexual intercourse, and eating certain foods due to symptoms, with average work days lost per year for patients with functional GI disorders being 14.8 compared to 8.7 in asymptomatic populations 4, 5
Patients experience anxiety, disturbed sleep, lethargy, and "inability to get on with their lives" such that the condition dominates their existence, with 15% of IBD patients accounting for 50% of healthcare expenditures 6, 2, 4, 5

Gastroenterologists must routinely assess health-related quality of life, symptom-specific anxiety, early life adversity, and functional impairment, with brain-gut psychotherapies (cognitive-behavioral therapy and gut-directed hypnotherapy) reducing symptom burden and healthcare utilization when integrated into GI practice 6, 2, 3

The American Gastroenterological Association notes that Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD) are distinct gastrointestinal functional disorders with specific characteristics, although they can coexist in 42-87% of patients 7, 8
IBS is characterized by recurrent abdominal pain or discomfort associated with defecation, changes in stool frequency or form, and alleviation of abdominal pain with defecation (although this only occurs in 10% of cases) 7, 9
FD is characterized by one or more symptoms including postprandial fullness, early satiety, and epigastric pain or burning, with symptoms localized mainly in the epigastric region 10
The Rome criteria are used to diagnose IBS, which includes recurrent abdominal pain associated with defecation and changes in stool frequency or form 9
The diagnosis of FD requires the presence of bothersome symptoms of epigastric pain or burning, early satiety, and/or postprandial fullness for more than 8 weeks 10

The American Gastroenterological Association recommends dietary modifications, including increased soluble fiber intake, and identification and reduction of trigger foods for IBS patients 9
Pharmacological treatment for IBS is based on subtype, with loperamide and bile acid sequestrants used for IBS-D, and increased dietary fiber and laxatives used for IBS-E 9
Antispasmodics, including peppermint oil, are used to treat abdominal pain in IBS patients 9
Eradication of Helicobacter pylori is recommended for FD patients who are infected 10
A stepped treatment approach is used for FD, with proton pump inhibitors or prokinetics as first-line treatment, and visceral analgesics (antidepressants) as second-line treatment 10

Establishing an effective and empathetic patient-physician relationship is essential for managing both IBS and FD 10
Explaining the pathophysiology and natural course of the condition to patients is important for their understanding and management of their symptoms 9, 10
Lifestyle modifications, stress management, and fitoterapéuticos and probiotics may be beneficial for both conditions 11